Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
Kurowska, Zuzanna LU ; Englund, Elisabet LU
; Widner, Håkan
LU
; Lindvall, Olle
LU
; Li, Jia-Yi
LU
and Brundin, Patrik
LU
(2011)
In Journal of Parkinson's Disease
1(1).
p.83-92
- Abstract
- We demonstrate that grafted human fetal mesencephalic neurons can survive and extend axons for 22 years in the brain of a patient with Parkinson's disease (PD). In this patient, the overall survival and fiber outgrowth of the grafts were, however, relatively poor, which is consistent with the lack of significant clinical graft-induced benefit. We have compared the morphology of neurons in the 22-year old grafts with those in two younger grafts (16- and 12-year old), which were sequentially implanted in another PD patient. In the case with the 22-year-old transplant, a high proportion (up to 38%) of the grafted dopaminergic (pigment-granule containing) neurons do not express tyrosine hydroxylase and dopamine transporter and their perikarya... (More)
- We demonstrate that grafted human fetal mesencephalic neurons can survive and extend axons for 22 years in the brain of a patient with Parkinson's disease (PD). In this patient, the overall survival and fiber outgrowth of the grafts were, however, relatively poor, which is consistent with the lack of significant clinical graft-induced benefit. We have compared the morphology of neurons in the 22-year old grafts with those in two younger grafts (16- and 12-year old), which were sequentially implanted in another PD patient. In the case with the 22-year-old transplant, a high proportion (up to 38%) of the grafted dopaminergic (pigment-granule containing) neurons do not express tyrosine hydroxylase and dopamine transporter and their perikarya appear atrophic. The proportion of pigmented neurons not expressing these markers is lower in the 12-16 year old grafts. Furthermore, in the 22-year-old graft, 49% of the pigmented neurons display alpha-synuclein immunoreactivity in the cell body and 1.2% of them contain Lewy bodies. In conclusion, our results show that grafted dopaminergic neurons can survive for more than two decades. However, over time an increasing proportion of grafted neurons exhibit signs of degeneration. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3470407
- author
- Kurowska, Zuzanna
LU
; Englund, Elisabet
LU
; Widner, Håkan
LU
; Lindvall, Olle
LU
; Li, Jia-Yi
LU
and Brundin, Patrik
LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Neural, transplantation, graft survival, dopamine, phenotype, tyrosine, hydroxylase, alpha-synuclein, Lewy bodies
- in
- Journal of Parkinson's Disease
- volume
- 1
- issue
- 1
- pages
- 83 - 92
- publisher
- IOS Press
- external identifiers
-
- wos:000308481700009
- scopus:79958227103
- pmid:23939259
- ISSN
- 1877-718X
- DOI
- 10.3233/JPD-2011-11004
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neuronal Survival (013212041), Pathology, (Lund) (013030000), Neurology, Lund (013027000), Neural Plasticity and Repair (013210080)
- id
- 0f8e807e-cff0-4da1-b8fc-437c0b43c0b9 (old id 3470407)
- date added to LUP
- 2016-04-01 11:13:42
- date last changed
- 2022-05-06 05:25:16
@article{0f8e807e-cff0-4da1-b8fc-437c0b43c0b9,
abstract = {{We demonstrate that grafted human fetal mesencephalic neurons can survive and extend axons for 22 years in the brain of a patient with Parkinson's disease (PD). In this patient, the overall survival and fiber outgrowth of the grafts were, however, relatively poor, which is consistent with the lack of significant clinical graft-induced benefit. We have compared the morphology of neurons in the 22-year old grafts with those in two younger grafts (16- and 12-year old), which were sequentially implanted in another PD patient. In the case with the 22-year-old transplant, a high proportion (up to 38%) of the grafted dopaminergic (pigment-granule containing) neurons do not express tyrosine hydroxylase and dopamine transporter and their perikarya appear atrophic. The proportion of pigmented neurons not expressing these markers is lower in the 12-16 year old grafts. Furthermore, in the 22-year-old graft, 49% of the pigmented neurons display alpha-synuclein immunoreactivity in the cell body and 1.2% of them contain Lewy bodies. In conclusion, our results show that grafted dopaminergic neurons can survive for more than two decades. However, over time an increasing proportion of grafted neurons exhibit signs of degeneration.}},
author = {{Kurowska, Zuzanna and Englund, Elisabet and Widner, Håkan and Lindvall, Olle and Li, Jia-Yi and Brundin, Patrik}},
issn = {{1877-718X}},
keywords = {{Neural; transplantation; graft survival; dopamine; phenotype; tyrosine; hydroxylase; alpha-synuclein; Lewy bodies}},
language = {{eng}},
number = {{1}},
pages = {{83--92}},
publisher = {{IOS Press}},
series = {{Journal of Parkinson's Disease}},
title = {{Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease}},
url = {{http://dx.doi.org/10.3233/JPD-2011-11004}},
doi = {{10.3233/JPD-2011-11004}},
volume = {{1}},
year = {{2011}},
}